Secondary Patents
Tuberculosis bedaquiline Johnson & Johnson’s TB drug deal will fail to reach all those in need

A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems